- Investing Ideas
- /
- Global Healthcare Large Cap High Growth Potential
Global Healthcare Large Cap High Growth Potential
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
39 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| GDRXGoodRx Holdings | US$42.06 | 2.7% | -16.1% | US$16.8b | US$43.79 | PS26.4x | E44.1% | n/a | ||
| 600763Topchoice Medical | CN¥235.03 | -21.2% | 8.8% | CN¥75.4b | CN¥361.54 | PE105.7x | E28.0% | 0% | ||
| 300015Aier Eye Hospital Group | CN¥47.27 | -8.1% | 9.0% | CN¥255.5b | CN¥73.63 | PE118.1x | E25.8% | 0.2% | ||
| 300760Shenzhen Mindray Bio-Medical Electronics | CN¥370.00 | 1.1% | 0.7% | CN¥449.8b | CN¥477.47 | PE59.6x | E20.8% | 0.7% | ||
| NVCRNovoCure | US$110.36 | -1.0% | -16.6% | US$11.6b | US$173.50 | PS20.9x | E79.8% | n/a | ||
| TDOCTeladoc Health | US$136.21 | 5.1% | -39.1% | US$21.6b | US$195.96 | PS13.3x | E56.1% | n/a | ||
| MOHMolina Healthcare | US$276.28 | -1.0% | 33.7% | US$16.1b | US$296.69 | PE25.5x | E21.4% | n/a | ||
| 241Alibaba Health Information Technology | HK$10.56 | -7.4% | -48.2% | HK$142.3b | HK$22.41 | PE337.8x | E28.8% | n/a | ||
| ALGNAlign Technology | US$595.13 | -5.8% | 82.1% | US$46.6b | US$733.79 | PE67.3x | E22.8% | n/a | ||
| DOCSDoximity | US$70.57 | 0.3% | n/a | US$13.0b | US$63.50 | PE405.7x | E24.9% | n/a | ||
| SN.Smith & Nephew | UK£12.61 | 0.3% | -15.4% | UK£11.1b | UK£16.05 | PE27.5x | E20.6% | 2.2% | ||
| MCKMcKesson | US$200.80 | -0.5% | 31.7% | US$31.1b | US$239.23 | PE-6.9x | E27.7% | 0.9% | ||
| SOONSonova Holding | CHF361.60 | 4.8% | 47.7% | CHF22.8b | CHF346.94 | PE39.3x | E10.5% | 0.9% | ||
| ABCAmerisourceBergen | US$118.38 | -3.3% | 21.0% | US$24.9b | US$141.62 | PB648x | E23.8% | 1.5% | ||
| SYKStryker | US$262.05 | 1.3% | 18.6% | US$100.4b | US$284.04 | PE47.4x | E22.7% | 1.0% | ||
| RDOR3Rede D'Or São Luiz | R$65.69 | -1.2% | n/a | R$129.5b | R$85.17 | PE90.3x | E31.5% | 0.3% | ||
| PODDInsulet | US$291.91 | -0.4% | 17.5% | US$20.7b | US$286.68 | PS20.2x | E49.9% | n/a | ||
| SRTSartorius | €577.00 | 1.9% | 83.8% | €37.8b | €418.19 | PE117.4x | E15.9% | 0.1% | ||
| AMPAmplifon | €41.85 | 3.1% | 30.0% | €9.4b | €40.45 | PE56.8x | E14.7% | 0.5% | ||
| ALCAlcon | CHF72.06 | -1.6% | 27.9% | CHF35.3b | CHF82.80 | PE208.9x | E26.9% | 0.1% | ||
| DXCMDexCom | US$541.28 | 2.4% | 36.2% | US$52.7b | US$531.81 | PE98.7x | E24.2% | n/a | ||
| A091990Celltrion Healthcare | ₩88,300.00 | 1.5% | 3.9% | ₩13.5t | ₩125,600.00 | PE63.5x | E27.0% | n/a | ||
| STMNStraumann Holding | CHF1,817.00 | 8.2% | 86.1% | CHF28.9b | CHF1,662.17 | PE80.8x | E15.5% | 0.3% | ||
| 7733Olympus | JP¥2,520.00 | 6.9% | 22.1% | JP¥3.2t | JP¥3,003.57 | PE38.4x | E13.2% | 0.6% |